CURV vs JILL

CURV exhibits critical financial distress, highlighted by a Piotroski F-Score of 0/9, indicating a total lack of fundamental improvement across all health metrics. The company is operating with negative equity (Price/Book: -0.85) and a severe liquidity crisis, evidenced by a Quick Ratio of 0.09. With revenue declining by 14.3% YoY and a 5-year price collapse of 92.4%, the business model appears to be in a state of terminal decline. The combination of negative margins and insider selling by the CFO further reinforces a high-risk profile.

JILL presents as a classic value trap candidate, characterized by a stable Piotroski F-Score of 4/9 and a Graham Number of $18.29 that suggests significant undervaluation. However, these metrics are countered by a critical liquidity profile, specifically a Quick Ratio of 0.35 and a razor-thin operating margin of 0.59%. While the company has a long history of beating earnings estimates, the recent YoY EPS collapse of -106.2% and negative revenue growth indicate a sharp deterioration in fundamentals. The stock is currently trading almost exactly at its growth-based intrinsic value of $12.74, providing little margin of safety despite the low P/E ratio.